Education
About Us
Working with TipRanks
Follow Us
Teladoc (GB:0LDR)
LSE:0LDR
0LDR Stock Chart & Stats
$8.56
-$0.24(-2.38%)
At close: 4:00 PM EST
$8.56
-$0.24(-2.38%)
Day’s Range― - ―
52-Week Range$6.53 - $15.18
Previous CloseN/A
Volume7.01K
Average Volume (3M)72.47K
Market Cap
$1.53B
Enterprise Value$1.68B
Total Cash (Recent Filing)$726.25M
Total Debt (Recent Filing)$1.03B
Price to Earnings (P/E)―
Beta1.58
Next Earnings
Feb 24, 2026EPS Estimate
-0.18Last Dividend Ex-Date
Mar 15, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding177,473,400
10 Day Avg. Volume65,982
30 Day Avg. Volume72,472
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.04
Price to Sales (P/S)0.60
P/FCF Ratio5.48
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue0.67
Enterprise Value/Gross Profit0.95
Enterprise Value/Ebitda-36.23
Forecast
1Y Price Target
$9.69Price Target Upside13.20% Upside
Rating ConsensusHold
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Expansion Of Insurance CoverageTeladoc's expansion of insurance coverage across more states is expected to build upon targeted insurance revenue, showing progress in addressing revenue headwinds.
Growth In Integrated CareIntegrated Care posted a revenue growth of 1.5% and exceeded adj-EBITDA estimates, driven by strong margins.
Stability And Growth StrategyTeladoc reaffirmed its 2025 annual guidance and provided preliminary 3Q'25 results that included revenue and adj-EBITDA within the expected ranges, illustrating business stability.
Bears Say
Decline In BetterHelp SalesBetterHelp sales fell 8% from the prior-year period with adjusted EBITDA down 75% year-over-year.
Margin PressureThere is an expectation of downward pressure to margins as TDOC invests for future growth.
Valuation And Growth ChallengesThe company’s valuation reflects the current turnaround situation due to lack of growth at the moment.
Teladoc News
0LDR FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest share price was $6.53 and its highest was $15.18 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $1.53B.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Feb 24, 2026 which is in 113 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Oct 29, 2025. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.264 by -$0.016.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc pays a Notavailable dividend of $0.285 which represents an annual dividend yield of N/A. See more information on Teladoc dividends here
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.18.
How many shares outstanding does Teladoc have?
Teladoc has 177,473,400 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.264. Following the earnings report the stock price went up 5.508%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in GB:0LDR
Teladoc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.69 (13.20% Upside)
$9.69 (13.20% Upside)
Blogger Sentiment
Bullish
GB:0LDR Sentiment 60%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-4.11%
12-Months-Change
Fundamentals
Return on Equity
-15.42%
Trailing 12-Months
Asset Growth
-18.42%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
0LDR Company Deck
0LDR Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Teladoc Health showed resilience with revenue and EBITDA exceeding guidance midpoints, strong international growth, and mental health expansion. However, challenges in BetterHelp's U.S. cash pay segment and a goodwill impairment charge weigh on the outlook.View all GB:0LDR earnings summaries0LDR Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
0LDR Stock 12 Month Forecast
Average Price Target
$9.69
▲(13.20% Upside)
Technical Analysis
Options Prices
Currently, No data available
---